General Overview of the Liver Transplant Patient
Liver transplantation (LT) is the only cure for end-stage liver disease. Almost 6000 liver transplants were performed in 2013, and more than 15,000 patients are on the liver transplant waiting list in the United States. Patient outcomes continue to improve with the majority of patients living more than 10 years after LT. With this increased life expectancy, attention to the long-term care of liver transplant recipients is paramount. In this chapter, we discuss the common medical conditions, the immunosuppression and antimicrobial prophylaxis regimens, and the approach to abnormal liver chemistry tests in the LT recipient.
KeywordsLiver transplant Abnormal liver chemistry tests Immunosuppression